Visiomed Group P/E 2024

Visiomed Group P/E

22.26

Visiomed Group Dividend yield

Ticker

ALVMG.PA

ISIN

FR0013481835

WKN

A2PZ7S

As of Mar 28, 2024, Visiomed Group's P/E ratio was 22.26, a 0% change from the 0 P/E ratio recorded in the previous year.

The Visiomed Group P/E history

Visiomed Group Aktienanalyse

What does Visiomed Group do?

The Visiomed Group SA, based in France and founded in 2007, is a globally operating company specializing in the development and distribution of medical devices and healthcare products. With a wide range of innovative medical devices and technologies, Visiomed has become a leading provider in this field. The business model of Visiomed is based on developing innovative technologies in the healthcare sector and bringing them to the global market. The company specifically invests in research and development as well as building strategic partnerships and distribution networks. Visiomed has divided itself into different sectors to offer its customers a broad range of healthcare products. The core areas of the company are Connected Health, Medical Care, and Oral Care. The Connected Health sector combines activities in the digital healthcare services and offers innovative solutions for monitoring and improving health. These include products such as ThermoFlash, the contactless infrared thermometer for measuring body temperature, or Bewell Connect, the system for monitoring blood pressure, pulse, and weight. In the Medical Care sector, Visiomed offers devices for medical diagnostics, therapy, and care. These include products such as the electronic stethoscope Stet-o-mate, the X'traseal wound care system, and the cable ECG Easy ECG. The Oral Care sector includes products for oral and dental care. These include the ZenCare electric ultrasonic toothbrush head, the OralJet tongue cleaner, and the Teeth Whitener teeth whitening set. Visiomed is proud to offer a variety of healthcare products tailored to the needs of consumers and professionals alike. The company is dedicated to providing its customers with innovative and effective solutions to improve healthcare worldwide. Visiomed Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Visiomed Group's P/E Ratio

The Price to Earnings (P/E) Ratio of Visiomed Group is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Visiomed Group's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Visiomed Group is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Visiomed Group’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Visiomed Group Stock

What is the price-to-earnings ratio of Visiomed Group?

The price-earnings ratio of Visiomed Group is currently 22.26.

How has the price-earnings ratio of Visiomed Group changed compared to last year?

The price-to-earnings ratio of Visiomed Group has increased by 0% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Visiomed Group high compared to other companies?

Yes, the price-to-earnings ratio of Visiomed Group is high compared to other companies.

How does an increase in the price-earnings ratio of Visiomed Group affect the company?

An increase in the price-earnings ratio of Visiomed Group would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Visiomed Group affect the company?

A decrease in the price-earnings ratio of Visiomed Group would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Visiomed Group?

Some factors that influence the price-earnings ratio of Visiomed Group are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Visiomed Group pay?

Over the past 12 months, Visiomed Group paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Visiomed Group is expected to pay a dividend of 0 EUR.

What is the dividend yield of Visiomed Group?

The current dividend yield of Visiomed Group is .

When does Visiomed Group pay dividends?

Visiomed Group pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Visiomed Group?

Visiomed Group paid dividends every year for the past 0 years.

What is the dividend of Visiomed Group?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Visiomed Group located?

Visiomed Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Visiomed Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Visiomed Group from 3/28/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 3/28/2024.

When did Visiomed Group pay the last dividend?

The last dividend was paid out on 3/28/2024.

What was the dividend of Visiomed Group in the year 2023?

In the year 2023, Visiomed Group distributed 0 EUR as dividends.

In which currency does Visiomed Group pay out the dividend?

The dividends of Visiomed Group are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Visiomed Group

Our stock analysis for Visiomed Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Visiomed Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.